APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 54 filers reported holding APPLIED GENETIC TECHNOL CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $116,000 | -64.8% | 428 | 0.0% | 0.00% | – |
| Q2 2022 | $330,000 | -28.6% | 428 | -0.9% | 0.00% | – |
| Q1 2022 | $462,000 | -98.6% | 432 | -97.6% | 0.00% | – |
| Q4 2021 | $33,917,000 | +2190.1% | 17,851 | +3528.3% | 0.00% | – |
| Q3 2021 | $1,481,000 | -9.4% | 492 | +17.7% | 0.00% | – |
| Q2 2021 | $1,634,000 | -98.0% | 418 | -97.4% | 0.00% | – |
| Q1 2021 | $81,561,000 | +302.8% | 16,087 | +225.0% | 0.00% | – |
| Q4 2020 | $20,246,000 | -25.4% | 4,950 | -11.3% | 0.00% | – |
| Q3 2020 | $27,129,000 | +458.3% | 5,582 | +536.5% | 0.00% | – |
| Q2 2020 | $4,859,000 | +69314.3% | 877 | +43750.0% | 0.00% | – |
| Q1 2020 | $7,000 | -22.2% | 2 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | -25.0% | 2 | -33.3% | 0.00% | – |
| Q3 2019 | $12,000 | +9.1% | 3 | 0.0% | 0.00% | – |
| Q2 2019 | $11,000 | -15.4% | 3 | 0.0% | 0.00% | – |
| Q1 2019 | $13,000 | -99.0% | 3 | -99.4% | 0.00% | – |
| Q4 2018 | $1,243,000 | -65.9% | 499 | 0.0% | 0.00% | – |
| Q3 2018 | $3,643,000 | +97.3% | 499 | 0.0% | 0.00% | – |
| Q2 2018 | $1,846,000 | -3.9% | 499 | 0.0% | 0.00% | – |
| Q1 2018 | $1,921,000 | +7.0% | 499 | 0.0% | 0.00% | – |
| Q4 2017 | $1,796,000 | -8.9% | 499 | 0.0% | 0.00% | – |
| Q3 2017 | $1,971,000 | -22.6% | 499 | 0.0% | 0.00% | – |
| Q2 2017 | $2,545,000 | -26.8% | 499 | -1.0% | 0.00% | – |
| Q1 2017 | $3,478,000 | +136.9% | 504 | +221.0% | 0.00% | – |
| Q4 2016 | $1,468,000 | -82.6% | 157 | -81.8% | 0.00% | – |
| Q3 2016 | $8,440,000 | +19.0% | 863 | +71.9% | 0.00% | – |
| Q2 2016 | $7,093,000 | +71.4% | 502 | +69.6% | 0.00% | – |
| Q1 2016 | $4,138,000 | -88.7% | 296 | -83.5% | 0.00% | – |
| Q4 2015 | $36,598,000 | +53.2% | 1,794 | -1.3% | 0.00% | – |
| Q3 2015 | $23,889,000 | +112.7% | 1,818 | +148.4% | 0.00% | – |
| Q2 2015 | $11,229,000 | +313.0% | 732 | +438.2% | 0.00% | – |
| Q1 2015 | $2,719,000 | -21.9% | 136 | -27.3% | 0.00% | – |
| Q3 2014 | $3,480,000 | – | 187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,455,904 | $7,075,000 | 2.04% |
| DAFNA Capital Management LLC | 1,095,139 | $5,322,000 | 1.73% |
| Portolan Capital Management | 1,301,075 | $6,323,000 | 0.72% |
| Sofinnova Investments, Inc. | 825,071 | $4,010,000 | 0.30% |
| Ikarian Capital, LLC | 545,884 | $2,654,000 | 0.19% |
| 683 Capital Management, LLC | 364,299 | $1,770,000 | 0.13% |
| Gyon Technologies Capital Management, LP | 18,653 | $91,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 336,900 | $1,637,000 | 0.07% |
| HighVista Strategies LLC | 15,200 | $74,000 | 0.05% |
| PURA VIDA INVESTMENTS, LLC | 176,411 | $857,000 | 0.04% |